Integration of DC vaccination in the primary treatment of adults with GBM: Update of the Pilot-Trial and the HGG-2006 phase I/II trial

Authors :: Hilko, A
van Gool, S
Maes, W
van Calenbergh, F
Goffin, J
van Loon, J
de Vleeschouwer, S
Source :: 60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien; 20090524-20090527; Münster; DOCMI.09-02 /20090520/
Publication Year :: 2009
Publisher :: German Medical Science GMS Publishing House, 2009.
Abstract: Objective: In spite of neurosurgery, radiochemotherapy (RCT) and maintenance temozolomide chemotherapy (TZMm), the prognosis of patients with GBM remains poor. Because immunotherapy opened new perspectives for patients at time of relapse, we are integrating immunotherapy in the primary postoperative[for full text, please go to the a.m. URL]<br />60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien

Language :: English
Database :: OpenAIRE
Journal :: 60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit den Benelux-Ländern und Bulgarien; 20090524-20090527; Münster; DOCMI.09-02 /20090520/
Accession number :: edsair.doi.dedup.....5f408755f344338777acf6bc9f67e38e
Full Text :: https://doi.org/10.3205/09dgnc231

Full Text Access

Tools